Impladent

Medical Equipment Manufacturing • Queens, New York, United States • 11-20 Employees

Company overview

Headquarters	86-90 188th St, New York, NY 11423, US
Website	impladentltd.com
NAICS	3391
SIC	384
Employees	11-20

Key Contacts at Impladent

Leslie Brooks

Director Of Professional Education Regenerative At Impladent Lltd

Lourdes Segura Codes

Directora Clínica Dental

Raquel Andreu

Directora

Dariusz Niesiobędzki

Principal Owner

Miguel Medina

Director

Impladent Email Formats

Impladent uses 1 email format. The most common is {first name} (e.g., john@impladentltd.com), used 100% of the time.

Format	Example	Percentage
{first name}	john@impladentltd.com	100%

About Impladent

Impladent Ltd. Impladent Ltd. develops and markets a broad range of innovative and affordable regenerative materials, including bone graft products and resorbable membranes. For over 35 years, Impladent Ltd. has been recognized as a leader in the innovation and development of synthetic resorbable bone grafts. In 1985, Impladent Ltd. introduced OsteoGen® Synthetic Bioactive Resorbable Graft (SBRG) used for bone augmentation and repair of alveolar defects. OsteoGen® Non-Ceramic Crystals are physiochemically and crystallographically equivalent to human trabecular bone making this product a pure alloplast. More recently, Impladent Ltd. introduced the OsteoGen® Bone Grafting Plugs, the one step solution for socket preservation without the need for a membrane. The OsteoGen® Plug combines our OsteoGen® bone graft with a bovine achilles tendon carrier to yield the easiest and most affordable way to graft your extraction sites. Impladent Ltd. is committed to developing regenerative products that meet the needs and interests of the doctor, while having the safety and comfort of the patient in mind.

Impladent revenue & valuation

Annual revenue	$941,105
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues	$3,100,000
Total funding	No funding